ALOK GOYAL: Open Payments
NPI 1487634036 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 43 payments from 19 companies in 2025. Trend: 2023 $1,416 · 2024 $1,073 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $151 |
| E.R. Squibb & Sons, L.L.C. | 4 | $101 |
| Neurocrine BioSciences, Inc. | 4 | $100 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Aimmune Therapeutics, Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $43 |
| Lundbeck LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $34 |
Products named: ELIQUIS, REXULTI, INGREZZA, Auvelity, QULIPTA, Kerendia, VRAYLAR, The Cologuard Plus Collection Kit.
Industry payments across WI — which companies pay providers there.
